Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy
about
MicroRNA-134 functions as a tumor suppressor gene in gastric cancerCo-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticlesGastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity
P2860
Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Engineering of lipid prodrug-b ...... ination gastric cancer therapy
@ast
Engineering of lipid prodrug-b ...... ination gastric cancer therapy
@en
type
label
Engineering of lipid prodrug-b ...... ination gastric cancer therapy
@ast
Engineering of lipid prodrug-b ...... ination gastric cancer therapy
@en
prefLabel
Engineering of lipid prodrug-b ...... ination gastric cancer therapy
@ast
Engineering of lipid prodrug-b ...... ination gastric cancer therapy
@en
P2093
P2860
P356
P1476
Engineering of lipid prodrug-b ...... ination gastric cancer therapy
@en
P2093
Chun-Ying Qu
Lei-Ming Xu
Mei-mei Chen
Ying-wei Chen
P2860
P304
P356
10.2147/IJN.S83211
P407
P577
2015-06-10T00:00:00Z